Titles
- Adverse events toolkit. Medical record review methodology1
- Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives1
- Air travel and communicable diseases: Federal leadership needed to advance research : report to congressional committees1
- Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives1
- Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry1
- An estimated 91 percent of nursing home staff nationwide received the required COVID-19 vaccine doses, and an estimated 56 percent of staff nationwide received a booster dose1
- Animal use in research: NIH should strengthen oversight of projects it funds at foreign facilities : report to congressional requesters1
- Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry1
- Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact1
- Antimicrobial susceptibility test (AST) system devices: updating breakpoints in device labeling : guidance for industry and Food and Drug Administration staff1
- Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees1
- Application of human factors engineering principles for combination products: questions and answers : guidance for industry and FDA staff1
- Arkansas Medicaid Fraud Control Unit: 2019 onsite inspection1
- Artificial intelligence in health care: benefits and challenges of machine learning technologies for medical diagnostics : report to congressional requesters1
- Assessing the California Children's Services Program1
- Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff1
- Assessing the effects of food on drugs in INDs and NDAs: clinical pharmacology considerations1
- Assez!!: la pharmacie est une cible facile pour le gouvernment1
- Assisted living in unlicensed housing: the regulatory experience of four states1